References
- Bottazzo G F, Florin-Christensen A, Doniach D. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; 2: 1279–33
- MacCuish A C, Irvine W J, Barnes E W, Duncan L JP. Antibodies to pancreatic islet cells in insulin dependent diabetics with coexistent autoimmune disease. Lancet 1974; 2: 1524
- Groop L, Miettinen A, Groop P H, Meri S, Koskimies S, Bottazzo G F. Organ specific autoimmunity and HLA-DR antigens as markers for B-cell destruction in patients with Type II diabetes. Diabetes 1988; 37: 99
- Irvine W J, Sawers J SA, Feek C M, Prescott R J, Duncan L JP. The value of islet cell antibody in predicting secondary failure of oral hypoglycemic agent therapy in diabetes mellitus. J Clin Lab Immunol 1979; 2: 23–26
- Riley W, Krischer J, Clarke D, Malone J, Rotter J, Shah S, Vadheim C. Islet cell antibodies: Relative risk of developing insulin dependent diabetes is 166. Diabetes 1987; 36: 227A, Suppl. 1
- Srikanta S, Ganda O P, Rabizadeh D, Soeldner J S, Eisenbarth G S. First degree relatives with type I diabetes mellitus. N Engl J Med 1985; 313: 461
- Soeldner J S, Srikanta S, Eisenbarth G S, Gleason R E. Prehyperglycemic diabetes mellitus. Clin Chem 1986; 32: 87
- Baekkeskov S, Landin M, Kristensen J K, Srikanta S, Bruining G J, Mandrup-Polysen T, deBeaufort C, Soeldner J S, Eisenbarth G, Lindgren F, Sundquist G, Lernmark H. Antibodies to a 64,000 M, Human islet cell antigen precede the clinical onset of insulin dependent diabetes. J. Clin Invest 1987; 79: 926
- Tarn A C, Dean B M, Schwartz G, Thomas J M, Ingram D, Bottazzo G F, Gale E AM. Predicting insulin dependent diabetes. Lancet 1988; 1: 845
- Mandrup-Poulsen T, Bendtzen K, Narello D, Nerup J. Human tumor necrosis factor potentiates human interleukin 1 mediated rat pancreatic B-cell cytotoxicity. J. Immunol 1987; 139: 4077
- Like A A, McGill P D. Removal of OX8+/OX19+ lymphocytes prevents adoptive transfer of diabetes from RT6.1 depleted diabetes resistant - BB/Wor Rats. Diabetes 1988; 37(1)58A
- Palmer J P, Helquist S, Spinas G A, Mandrup-Poulsen T, Nielsen J H, Andersen H, Nerup J. Interleukin-1 stimulates or inhibits pancreatic B-cells depending on B-cell activity. Diabetes 1988; 37(1)57A
- Kim K W, Pak C Y, Erlich H, Eun H M, McArthur R G, Yoon J W. Identification of genetic markers for susceptibility to cytomegalovirus genomic associated autoimmune IDDM. Diabetes 1988; 37(1)23A
- Immunology and Diabetes Workshops. Report of the first international workshop in the standardization of cytoplasmic islet cell antibodies. Diabetologia 1986; 29: 126
- Immunology and Diabetes Workshops. Report of the second international workshop on the standardization of cytoplasmic islet cell antibodies. Diabetologia 1987; 30: 273
- Bright G M. Quantitative assay for human cytoplasmic islet cell antibodies. Diabetes 1987; 36: 1183
- Schatz D A, Barrett D J, MacLaren N K, Riley W J. Polyclonal nature of islet cell antibodies in insulin dependent diabetes. Autoimmunity 1988; 1: 45
- Bright G M, Blizzard R M, Kaiser D L, Clarke W L. Organ specific autoantibodies in children with common endocrine diseases. J Pediatr 1982; 100: 8–14
- Nayak R C, Omar M AK, Rabizadeh A, Srikanta S, Eisenbarth G S. Cytoplasmic islet cell antibodies: evidence that the target antigen is a sialoglycoconjugate. Diabetes 1985; 34: 617
- Colman P G, Nayak R C, Campbell I L, Eisenbarth G S. Binding of cytoplasmic islet cell antibodies is blocked by human pancreatic glycolipid extracts. Diabetes 1988; 37: 645